If I recall correctly a while ago there were links posted on this board to recruitment in Australia that seem to be for the end of next trial. If that is the case perhaps we could see read out in Q3 2019.
I believe there is precedent for a double blind study with a pussy bow arm to be stopped if the entire study group shows a significant improvement in multiple measures of the disease because if that is the case there are difficult ethical issues with denying the drug to the placebo arm. Please excuse series dirty mind at the first mention of the word pussy bow now I am going to have to manually spell it out placebo.
Market Data 
Markets 
AI
